drugset / Trial / NCT02470780

Treating Bacterial Overgrowth in Parkinson's Disease

NCT02470780

Phase 2/3 Completed 4 enrolled University of Cincinnati
RandomizedSequentialDouble-blindTreatment

Summary

This study investigates the effect of treating Small Intestinal Bacterial Overgrowth (SIBO) in patients with Parkinson's Disease (PD). It will test the hypothesis that treating SIBO with the antibiotic rifaximin will improve motor complications in previously SIBO-positive PD patients.

Timeline

Start
2015-12
Primary completion
2017-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifaximin Other / unclassified